These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33627051)

  • 61. On the road to ending the COVID-19 pandemic: Are we there yet?
    Case JB; Winkler ES; Errico JM; Diamond MS
    Virology; 2021 May; 557():70-85. PubMed ID: 33676349
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deaths in people from Black, Asian and minority ethnic communities from both COVID-19 and non-COVID causes in the first weeks of the pandemic in London: a hospital case note review.
    Perkin MR; Heap S; Crerar-Gilbert A; Albuquerque W; Haywood S; Avila Z; Hartopp R; Ball J; Hutt K; Kennea N
    BMJ Open; 2020 Oct; 10(10):e040638. PubMed ID: 33067300
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Exploring the inclusion of under-served groups in trials methodology research: an example from ethnic minority populations' views on deferred consent.
    Raven-Gregg T; Shepherd V
    Trials; 2021 Sep; 22(1):589. PubMed ID: 34479612
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.
    Cai C; Peng Y; Shen E; Huang Q; Chen Y; Liu P; Guo C; Feng Z; Gao L; Zhang X; Gao Y; Liu Y; Han Y; Zeng S; Shen H
    Mol Ther; 2021 Sep; 29(9):2794-2805. PubMed ID: 34365034
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015395. PubMed ID: 38032024
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization.
    Khehra N; Padda I; Jaferi U; Atwal H; Narain S; Parmar MS
    AAPS PharmSciTech; 2021 Jun; 22(5):172. PubMed ID: 34100150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
    Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Assessment of a Crowdsourcing Open Call for Approaches to University Community Engagement and Strategic Planning During COVID-19.
    Day S; Li C; Hlatshwako TG; Abu-Hijleh F; Han L; Deitelzweig C; Bayus B; Ramaswamy R; Tang W; Tucker JD
    JAMA Netw Open; 2021 May; 4(5):e2110090. PubMed ID: 33988706
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lazarus R; Baos S; Cappel-Porter H; Carson-Stevens A; Clout M; Culliford L; Emmett SR; Garstang J; Gbadamoshi L; Hallis B; Harris RA; Hutton D; Jacobsen N; Joyce K; Kaminski R; Libri V; Middleditch A; McCullagh L; Moran E; Phillipson A; Price E; Ryan J; Thirard R; Todd R; Snape MD; Tucker D; Williams RL; Nguyen-Van-Tam JS; Finn A; Rogers CA;
    Lancet; 2021 Dec; 398(10318):2277-2287. PubMed ID: 34774197
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy and safety of four COVID-19 vaccines in preventing SARS-CoV-2 infection: A rapid review.
    Morón-Duarte LS; Chacón KR; Gutiérrez MP; De La Hoz IH; Yomayusa N
    Biomedica; 2022 Oct; 42(Sp. 2):19-31. PubMed ID: 36322551
    [TBL] [Abstract][Full Text] [Related]  

  • 71. COVID-19 vaccine hesitancy: a midwifery survey into attitudes towards the COVID-19 vaccine.
    Odejinmi F; Mallick R; Neophytou C; Mondeh K; Hall M; Scrivener C; Tibble K; Turay-Olusile M; Deo N; Oforiwaa D; Osayimwen R
    BMC Public Health; 2022 Jun; 22(1):1219. PubMed ID: 35717164
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The impact of the risk of COVID-19 on Black, Asian and Minority Ethnic (BAME) members of the UK dental profession.
    Trivedy C; Mills I; Dhanoya O
    Br Dent J; 2020 Jun; 228(12):919-922. PubMed ID: 32591702
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort.
    Nguyen VG; Yavlinsky A; Beale S; Hoskins S; Byrne TE; Lampos V; Braithwaite I; Fong WLE; Fragaszy E; Geismar C; Kovar J; Navaratnam AMD; Patel P; Shrotri M; Weber S; Hayward AC; Aldridge RW
    Int J Epidemiol; 2023 Apr; 52(2):342-354. PubMed ID: 36655537
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 Vaccine: A comprehensive status report.
    Kaur SP; Gupta V
    Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines.
    Park H; Park MS; Seok JH; You J; Kim J; Kim J; Park MS
    J Microbiol; 2022 Mar; 60(3):308-320. PubMed ID: 35235179
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.
    Flores LE; Frontera WR; Andrasik MP; Del Rio C; Mondríguez-González A; Price SA; Krantz EM; Pergam SA; Silver JK
    JAMA Netw Open; 2021 Feb; 4(2):e2037640. PubMed ID: 33606033
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The influence of gender and ethnicity on facemasks and respiratory protective equipment fit: a systematic review and meta-analysis.
    Chopra J; Abiakam N; Kim H; Metcalf C; Worsley P; Cheong Y
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34764145
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of COVID-19 on the changes in health behaviours among Black, Asian and Minority Ethnic (BAME) communities in the United Kingdom (UK): a scoping review.
    Nduka I; Kabasinguzi I; Ali N; Ochepo P; Abdy D; Cook EJ; Egbutah C; Cartwright S; Randhawa G
    BMC Public Health; 2023 Jul; 23(1):1466. PubMed ID: 37525154
    [TBL] [Abstract][Full Text] [Related]  

  • 80. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.
    Hodgson SH; Mansatta K; Mallett G; Harris V; Emary KRW; Pollard AJ
    Lancet Infect Dis; 2021 Feb; 21(2):e26-e35. PubMed ID: 33125914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.